These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 27493216)

  • 21. Fukutin and alpha-dystroglycanopathies.
    Toda T; Chiyonobu T; Xiong H; Tachikawa M; Kobayashi K; Manya H; Takeda S; Taniguchi M; Kurahashi H; Endo T
    Acta Myol; 2005 Oct; 24(2):60-3. PubMed ID: 16550916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CDP-glycerol inhibits the synthesis of the functional
    Imae R; Manya H; Tsumoto H; Osumi K; Tanaka T; Mizuno M; Kanagawa M; Kobayashi K; Toda T; Endo T
    J Biol Chem; 2018 Aug; 293(31):12186-12198. PubMed ID: 29884773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. O-mannosylation in mammalian cells.
    Endo T; Manya H
    Methods Mol Biol; 2006; 347():43-56. PubMed ID: 17072003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Muscular Dystrophy Gene TMEM5 Encodes a Ribitol β1,4-Xylosyltransferase Required for the Functional Glycosylation of Dystroglycan.
    Manya H; Yamaguchi Y; Kanagawa M; Kobayashi K; Tajiri M; Akasaka-Manya K; Kawakami H; Mizuno M; Wada Y; Toda T; Endo T
    J Biol Chem; 2016 Nov; 291(47):24618-24627. PubMed ID: 27733679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanistic aspects of the formation of α-dystroglycan and therapeutic research for the treatment of α-dystroglycanopathy: A review.
    Taniguchi-Ikeda M; Morioka I; Iijima K; Toda T
    Mol Aspects Med; 2016 Oct; 51():115-24. PubMed ID: 27421908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Site mapping and characterization of O-glycan structures on alpha-dystroglycan isolated from rabbit skeletal muscle.
    Stalnaker SH; Hashmi S; Lim JM; Aoki K; Porterfield M; Gutierrez-Sanchez G; Wheeler J; Ervasti JM; Bergmann C; Tiemeyer M; Wells L
    J Biol Chem; 2010 Aug; 285(32):24882-91. PubMed ID: 20507986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical correlation of activity of the α-dystroglycan-modifying glycosyltransferase POMGnT1 with mutations in muscle-eye-brain disease.
    Voglmeir J; Kaloo S; Laurent N; Meloni MM; Bohlmann L; Wilson IB; Flitsch SL
    Biochem J; 2011 Jun; 436(2):447-55. PubMed ID: 21361872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurons and glia modify receptor protein-tyrosine phosphatase ζ (RPTPζ)/phosphacan with cell-specific O-mannosyl glycans in the developing brain.
    Dwyer CA; Katoh T; Tiemeyer M; Matthews RT
    J Biol Chem; 2015 Apr; 290(16):10256-73. PubMed ID: 25737452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic glycopeptides reveal specific binding pattern and conformational change at O-mannosylated position of α-dystroglycan by POMGnT1 catalyzed GlcNAc modification.
    Hinou H; Kikuchi S; Ochi R; Igarashi K; Takada W; Nishimura SI
    Bioorg Med Chem; 2019 Jul; 27(13):2822-2831. PubMed ID: 31079966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of post-phosphoryl modification in dystroglycanopathy mouse models and wild-type tissues expressing non-laminin binding form of α-dystroglycan.
    Kuga A; Kanagawa M; Sudo A; Chan YM; Tajiri M; Manya H; Kikkawa Y; Nomizu M; Kobayashi K; Endo T; Lu QL; Wada Y; Toda T
    J Biol Chem; 2012 Mar; 287(12):9560-7. PubMed ID: 22270369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. POMGNT1 Is Glycosylated by Mucin-Type O-Glycans.
    Xin X; Akasaka-Manya K; Manya H; Furukawa J; Kuwahara N; Okada K; Tsumoto H; Higashi N; Kato R; Shinohara Y; Irimura T; Endo T
    Biol Pharm Bull; 2015; 38(9):1389-94. PubMed ID: 26328495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1.
    Yoshida A; Kobayashi K; Manya H; Taniguchi K; Kano H; Mizuno M; Inazu T; Mitsuhashi H; Takahashi S; Takeuchi M; Herrmann R; Straub V; Talim B; Voit T; Topaloglu H; Toda T; Endo T
    Dev Cell; 2001 Nov; 1(5):717-24. PubMed ID: 11709191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome.
    Beltrán-Valero de Bernabé D; Currier S; Steinbrecher A; Celli J; van Beusekom E; van der Zwaag B; Kayserili H; Merlini L; Chitayat D; Dobyns WB; Cormand B; Lehesjoki AE; Cruces J; Voit T; Walsh CA; van Bokhoven H; Brunner HG
    Am J Hum Genet; 2002 Nov; 71(5):1033-43. PubMed ID: 12369018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HNK-1 sulfotransferase-dependent sulfation regulating laminin-binding glycans occurs in the post-phosphoryl moiety on α-dystroglycan.
    Nakagawa N; Takematsu H; Oka S
    Glycobiology; 2013 Sep; 23(9):1066-74. PubMed ID: 23723439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro.
    Miyagoe-Suzuki Y; Masubuchi N; Miyamoto K; Wada MR; Yuasa S; Saito F; Matsumura K; Kanesaki H; Kudo A; Manya H; Endo T; Takeda S
    Mech Dev; 2009; 126(3-4):107-16. PubMed ID: 19114101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental expression of the neuron-specific N-acetylglucosaminyltransferase Vb (GnT-Vb/IX) and identification of its in vivo glycan products in comparison with those of its paralog, GnT-V.
    Lee JK; Matthews RT; Lim JM; Swanier K; Wells L; Pierce JM
    J Biol Chem; 2012 Aug; 287(34):28526-36. PubMed ID: 22715095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AGO61-dependent GlcNAc modification primes the formation of functional glycans on α-dystroglycan.
    Yagi H; Nakagawa N; Saito T; Kiyonari H; Abe T; Toda T; Wu SW; Khoo KH; Oka S; Kato K
    Sci Rep; 2013 Nov; 3():3288. PubMed ID: 24256719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression pattern in retinal photoreceptors of POMGnT1, a protein involved in muscle-eye-brain disease.
    Uribe ML; Haro C; Ventero MP; Campello L; Cruces J; Martín-Nieto J
    Mol Vis; 2016; 22():658-73. PubMed ID: 27375352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical spectrum of muscle-eye-brain disease: from the typical presentation to severe autistic features.
    Haliloglu G; Gross C; Senbil N; Talim B; Hehr U; Uyanik G; Winkler J; Topaloglu H
    Acta Myol; 2004 Dec; 23(3):137-9. PubMed ID: 15938569
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.